Cannell & Spears’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.9M Sell
171,407
-10,306
-6% -$2.4M 0.82% 37
2025
Q4
$37.6M Sell
181,713
-730
-0.4% -$144K 0.7% 38
2025
Q3
$33.8M Sell
182,443
-4,487
-2% -$769K 0.64% 46
2025
Q2
$28.6M Buy
186,930
+3,038
+2% +$467K 0.58% 53
2025
Q1
$30.5M Buy
183,892
+15,750
+9% +$2.46M 0.66% 47
2024
Q4
$24.3M Sell
168,142
-2,064
-1% -$320K 0.5% 59
2024
Q3
$27.6M Sell
170,206
-258
-0.2% -$41.1K 0.54% 57
2024
Q2
$24.9M Sell
170,464
-1,762
-1% -$262K 0.52% 60
2024
Q1
$27.2M Buy
172,226
+124,764
+263% +$19.9M 0.56% 58
2023
Q4
$7.44M Sell
47,462
-5,782
-11% -$887K 0.59% 28
2023
Q3
$8.29M Sell
53,244
-1,220
-2% -$201K 0.71% 29
2023
Q2
$9.01M Buy
54,464
+18
+0% +$2.9K 0.74% 29
2023
Q1
$8.44M Buy
54,446
+621
+1% +$100K 0.76% 29
2022
Q4
$9.51M Sell
53,825
-5,188
-9% -$896K 0.91% 29
2022
Q3
$9.64M Sell
59,013
-157
-0.3% -$26.6K 0.95% 29
2022
Q2
$10.5M Buy
59,170
+83
+0.1% +$14.8K 0.95% 28
2022
Q1
$10.5M Sell
59,087
-1,480
-2% -$252K 0.78% 27
2021
Q4
$10.4M Buy
60,567
+5,209
+9% +$853K 0.7% 29
2021
Q3
$8.94M Hold
55,358
0.65% 29
2021
Q2
$9.12M Buy
55,358
+491
+0.9% +$81.3K 0.66% 30
2021
Q1
$9.02M Sell
54,867
-43
-0.1% -$6.96K 0.7% 30
2020
Q4
$8.64M Sell
54,910
-1,250
-2% -$184K 0.72% 28
2020
Q3
$8.36M Buy
56,160
+135
+0.2% +$20K 0.8% 26
2020
Q2
$7.88M Buy
56,025
+536
+1% +$78.1K 0.83% 26
2020
Q1
$7.28M Buy
55,489
+1,415
+3% +$201K 0.89% 26
2019
Q4
$7.89M Buy
54,074
+499
+0.9% +$67.7K 0.84% 27
2019
Q3
$6.93M Sell
53,575
-1,088
-2% -$143K 0.8% 25
2019
Q2
$7.61M Sell
54,663
-1,835
-3% -$254K 0.89% 24
2019
Q1
$7.9M Sell
56,498
-250
-0.4% -$33.5K 1.01% 23
2018
Q4
$7.32M Sell
56,748
-1,391
-2% -$194K 1.07% 24
2018
Q3
$8.03M Hold
58,139
0.96% 26
2018
Q2
$7.05M Buy
58,139
+7
+0% +$873 0.92% 26
2018
Q1
$7.45M Sell
58,132
-2,515
-4% -$340K 0.97% 25
2017
Q4
$8.47M Buy
60,647
+9,248
+18% +$1.29M 1.03% 26
2017
Q3
$6.68M Hold
51,399
0.8% 27
2017
Q2
$6.8M Buy
51,399
+405
+0.8% +$51.7K 0.85% 27
2017
Q1
$6.35M Sell
50,994
-220
-0.4% -$26.3K 0.8% 27
2016
Q4
$5.9M Buy
51,214
+2,283
+5% +$264K 0.76% 27
2016
Q3
$5.78M Sell
48,931
-800
-2% -$97.1K 0.73% 27
2016
Q2
$6.03M Sell
49,731
-260
-0.5% -$29.5K 0.77% 26
2016
Q1
$5.41M Buy
49,991
+900
+2% +$93.2K 0.66% 26
2015
Q4
$5.04M Sell
49,091
-1,900
-4% -$191K 0.58% 27
2015
Q3
$4.76M Buy
50,991
+400
+0.8% +$38.7K 0.54% 27
2015
Q2
$4.93M Sell
50,591
-3,940
-7% -$395K 0.55% 27
2015
Q1
$5.49M Buy
54,531
+634
+1% +$64.5K 0.66% 26
2014
Q4
$5.64M Hold
53,897
0.63% 31
2014
Q3
$5.75M Buy
53,897
+438
+0.8% +$45.4K 0.69% 31
2014
Q2
$5.59M Buy
53,459
+815
+2% +$82.4K 0.66% 31
2014
Q1
$5.17M Buy
52,644
+600
+1% +$55.6K 0.65% 32
2013
Q4
$4.77M Hold
52,044
0.6% 32
2013
Q3
$4.51M Buy
52,044
+4,960
+11% +$445K 0.59% 33
2013
Q2
$4.04M Buy
+47,084
New +$4M 0.6% 32

Other funds holding JNJ

Cannell & Spears's JNJ Position: Q1 2026 in Review

Cannell & Spears reduced its Johnson & Johnson (JNJ) stake by 5.7% in Q1 2026, selling an estimated $2.4M and leaving 171,407 shares worth $41.9M. The position accounts for 0.82% of the portfolio, ranked #37.

Cannell & Spears first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cannell & Spears held 171,407 shares of Johnson & Johnson worth $41.9M as of Q1 2026.
  • Cannell & Spears sold 10,306 Johnson & Johnson shares in Q1 2026, an estimated $2.4M.
  • Johnson & Johnson made up 0.82% of Cannell & Spears's portfolio in Q1 2026, its #37 holding.
  • Cannell & Spears first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.